Results 31 to 40 of about 10,516 (266)

AIP variant causing familial prolactinoma [PDF]

open access: yes, 2020
Pathogenic variants in the aryl hydrocarbon receptor-interacting protein (AIP) gene are increasingly recognised as a cause of familial isolated pituitary adenoma. AIP-associated tumours are most commonly growth hormone (GH) producing.
Magid, K   +15 more
core   +1 more source

Hyperprolactinemia in children and adolescents and longterm follow-up results of prolactinoma cases: a single-centre experience

open access: yesThe Turkish Journal of Pediatrics, 2022
Background. Hyperprolactinaemia refers to increased circulating prolactin and is divided into functional and pathological hyperprolactinaemia. Prolactinoma is the most common cause of severe hyperprolactinaemia. Prolactinomas are rare in children.
Tuğba Kontbay   +6 more
doaj   +1 more source

The side effects of dopamine receptor agonist drugs in Chinese prolactinoma patients: a cross sectional study

open access: yesBMC Endocrine Disorders, 2022
Background Recently, side effects from Dopamine Receptor Agonist Drugs (DAs) in treating pituitary prolactinoma have raised widespread concern. This study explores the incidence and influencing factors of DAs-related side effects in Chinese prolactinoma ...
Xiaoan Ke   +7 more
doaj   +1 more source

Giant Prolactinoma: Challenges in Management. [PDF]

open access: yesAACE Endocrinol Diabetes
Background/Objective: Prolactinomas are the most common form of pituitary adenomas, 90% of which are microprolactinomas measuring \u3c 1 cm. A giant prolactinoma is defined as a prolactinoma measuring \u3e4 cm with a serum prolactin level of \u3e1000 ng ...
Sharma S, Acharya M, Sherpa C.
europepmc   +2 more sources

AIP variant causing familial prolactinoma

open access: yes, 2021
Pathogenic variants in the aryl hydrocarbon receptor-interacting protein (AIP) gene are increasingly recognised as a cause of familial isolated pituitary adenoma. AIP-associated tumours are most commonly growth hormone (GH) producing.
Owens, Martina, Ward, Rebecca
core   +1 more source

Giant Prolactinoma Causing Hydrocephalus and Intracranial Hypertension as First Manifestations of Multiple Endocrine Neoplasia Type 1

open access: yesFrontiers in Endocrinology, 2019
Context: Overall, giant prolactinomas are rare tumors (4%), especially those larger than 60 mm (1%). Despite the predominance of macroadenoma documented in multiple endocrine neoplasia type 1 (MEN1)-related prolactinoma, only three giant prolactinoma ...
Naiara C. B. Dantas   +6 more
doaj   +1 more source

Increased Lipid Levels Improves after Treatment with Cabergolin in Patients with Prolactinoma

open access: yesMedicine Science, 2015
It has been suggested that hyperprolactinemia may be associated with obesity and dyslipidemia. However it is not fully understood that dyslipidemia is occurs independently or due to obesity.
Mazhar Muslum Tuna   +5 more
doaj   +1 more source

A Novel Case of Spontaneous Coronary Artery Dissection During Cabergoline Therapy for Prolactinoma

open access: yesJACC: Case Reports, 2020
We present a case of spontaneous coronary artery dissection associated with cabergoline treatment for prolactinoma. A 31-year-old woman with history of hypertension and prolactinoma, treated with cabergoline, presented with chest pain.
Shinichiro Ikeda, MD   +3 more
doaj   +1 more source

A giant invasive macroprolactinoma with recurrent nasal bleeding as the first clinical presentation: case report and review of literature

open access: yesBMC Endocrine Disorders, 2023
Background Giant prolactinoma (> 4 cm in dimension) is a rare disorder. Invasive macroprolactinoma has the potential to cause base of skull erosion and extend into the nasal cavity or even the sphenoid sinus.
Danting Li   +4 more
doaj   +1 more source

Treating prolactinoma and psychosis: Medication and cognitive behavioural therapy. [PDF]

open access: yes, 2011
The patient in this case report had two severe medical conditions that require oppositional treatment: prolactinoma and psychosis. A prolactinoma is a benign tumour of the pituitary gland that produces prolactin.
Nieman, D. H.   +22 more
core   +1 more source

Home - About - Disclaimer - Privacy